Features and Assessments of Pain, Anaesthesia and Analgesia: I. Setting the scene: General aspects of anesthesia, analgesics and pain 1. The concept of multimorphic cancer pain: a new approach from diagnosis to treatment; 2. Recent advances in the linkage of attachment and pain: a new review; 3. The management of pain in older peopleFelicity; 4. Anesthesia and body mass: epidural depth and beyond; 5. Anesthetics and analgesic activities of herbal medicine: Review of the possible mechanism of action; 6. Analgesia-first sedation and multimodal analgesia in the intensive care unit; 7.
The multidisciplinary Acute Pain Service: features and experiences; 8. Monitoring anaesthesia: EEG and beyhond II. The syndromes of pain 9. Cluster headache and pain: features and treatments; 10. Migraine and pain: features and treatments; 11. Complex regional pain syndrome; 12. Phantom limb pain; 13. Painful diabetic neuropathy: The roles of microglia; 14.
Maternal deprivation and nociceptiionIraci; 15. Giving birth and pain; 16. Abdominal Pain in Gastroparesi; 17. Appendicitis and related abdominal pain; 18. Ovarian hormones, site-specific nociception and hypertension; 19. Linking the heart and pain: physiological and psychophysiological mechanisms; 20. Chronic pain in military veterans; 21. Nociception during surgery; 22.
Breast cancer and nociception; 23. Postoperative pain after rhinoplasty and rhinologic surgery; 24. Pain response, neonates and venipuncture; 25. Carpal tunnel syndrome and pain; 26. Pain and HIV; 27. Pain mechanisms in computer and smartphone users III. Interlinking anesthesia, analgesics and pain 28. Patients'' and health professionals'' positions regarding the use of analgesics in cancer cases; 29.
Linking compression of myofascial trigger points and musculoskeletal pain; 30. Multimodal analgesia and post-surgical pain; 31. Pain, ultrasound-guided Pecs II block and general anesthesia; 32. Pain control during prostate biopsy and evolution of local anesthesia techniqes; 33. Pain reduction, in cosmetic injections: fillers and beyond; 34. Anesthesia and combat-related extremity injury; 35. Spinal anesthesia: applications to cesarean section and pain; 36. Postoperative Pain Management: Truncal blocks in thoracic surgery; 37.
Postoperative Pain Management: Truncal blocks in general surgery; 38. Linking analgesia, epidural oxycodone, pain and laparoscopy; 39. Levobupivacaine features and linking in infiltrating analgesia IV. Assessments, screening and resources 40. The Pain Catastrophizing Scale: Features and Applications; 41. The Pain Behaviour Scale (PaBS); 42. The analgesia nociception index: features and application; 43. Back Pain Evaluation Questionnaire; 44.
The Back Pain Functional Scale: features and applications; 45. Cognitive impairment, pain and analgesia; 46. Biomarkers in endometriosis-associated pain; 47. Biomarkers in bladder pain syndrome: a new narrative; 48. Biomarkers of statin-induced musculoskeletal pain: Vitamin D and beyond; 49. Performance-based and self-reported physical fitness as a powerful marker of musculoskeletal pain Treatments, Mechanisms, and Adverse Reactions of Anesthetics and Analgesics: I. Drugs and agents used in anesthesia and analgesia 1. Anesthesia for malignant hyperthermia susceptible patients; 2.
Use of dextran in regional anesthesia; 3. Intraperitoneal local anesthetic agents in the management of post-operative pain; 4. Automatic control of anesthesia via different vital signs; 5. Non-opioid based analgesia in otolaryngology II. Mechanisms of action of drugs 6. Buprenorphine: mechanisms and applications; 7. Caffeine usage in pain management; 8. Chloroprocaine: features and applications; 9.
Clonidine: features and applications; 10. An excursion into secondary pharmacology of fentanyls with potential implications for drug design: s1 receptor; 11. Isoflurane: mechanisms and applications; 12. The lidocaine patch: features and applications: post-thoracotomy pain and beyond; 13. Memantine: features and application to chronic pain control; 14. Midazolam: Perioperative administration; 15. Intravenous paracetamol: features and applications; 16. Prilocaine: mechanisms and applications; 17.
Sevoflurane: features and use in topical application for wound care; 18. Tramadol as an analgesic III. Adverse effects, reactions and outcomes 19. Long-term effects of anaesthesia on the brain: an update on neurotoxicity; 20. Neuraxial labour analgesia and breast feeding; 21. Mechanistic Overview of How Opioid Analgesics Promote Constipation; 22. Cognitive-behavioral therapy for opioid use disorder and chronic pain; 23. Preoperative opioid and benzodiazepines: impact on adverse outcomes; 24.
Anesthetics, Malignant hyperthermia syndrome and Kv7 channels; 25. Problems with epidural catheter; 26. Headache after neuroaxial blocks: a focus on combined-epidural anesthesia; 27. Liposomal bupivacaine, pain relief and adverse events; 28. Adverse events associate with analgesics: a focus on paracetamol use IV. Novel and non-pharmacological aspects and treatments 29. Acronychia pedunculata leaves and usage in pain; 30. Adansonia digitata and use in neuropathic pain: prostaglandins and beyond; 31.
Andrographis paniculata standardized extract (ParActin) and pain; 32. Capsaicin: features usage in diabetic neuropathic pain; 33. Cola nitida and Pain reliefLawrence; 34. Analgesic effects of Ephedra Herb extract and ephedrine alkaloids-free Ephedra Herb extract (EFE); 35. Euphorbia bicolor (Euphorbiaceae) Latex Phytochemicals and applications to analgesia; 36. Pain relieving activity of muntingia calabura l.: elucidation of possible mechanisms of action and identification of responsible phytoconstituents; 37. Resolving neuroinflammation and pain with Maresin 1, a specialized pro-resolving lipid mediator; 38.
Therapeutic role of naringenin to alleviate inflammatory pain; 39. Analgesic properties of Solanum paniculatum and S.torvum extracts; 40. Dietary constituents contribute to local anesthetic agent: neurophysiologicals mechanism of nociceptive pain; 41. Pain response following prenatal stress and its modulation by antioxidants; 42. Physical activity and fitness in the prevention of musculoskeletal pain in youth; 43. Linking aerobic exercise and childhood pain alleviation: a narrative; 44. Physical activity and exercise in the management of musculoskeletal pain: a focus on fibromyalgia; 45.
Spinal cord stimulation and limb pain; 46. Effectiveness of neural mobilization on pain and disability in individuals with musculoskeletal disorders; 47. Virtual reality and applications to treating neck pain; 48. Virtual reality-induced analgesia and dental pain; 49. Vibrotactile devices, DentalVibe and local anesthesiaElitsa; 50. Cooled radiofrequency ablation (CRFA) and osteoarthritis treatment for pain; 51. Non-pharmacologic analgesic therapies: a focus on photobiomodulation, acustimulation and cryoanalgesia (ice) therapy; 52. New coping strategies and self-education for chronic pain management: e-health; 53.
Postoperative Pain Management Truncal blocks in obstetric and gynecologic surgery The Neurobiology, Physiology and Psychology of Pain I. Molecular and cellular aspects 1. Gene expression, KCNQ/Kv7 channels and neuropathic pain; 2. The NTRK1 gene and congenital insensitivity to pain; 3. Prdm12, a key transcriptional regulator of the nociceptive lineage; 4. Linking the genetics of fibromyalgia and painFernando; 5. Fentanyl: Polymorphisms, and adverse events; 6. Propofol anesthesia and molecular changes in the brain; 7.
Protein Kinase G is a Molecular Switch for Pain; 8. Adrenergic agonists and the mu opioid receptor; 9. Inflammatory and neuropathic pain impact on the opioid function in the mesocorticolimbic systemL; 10. Clinacanthus nutans, analgesia and the l-arginine/nitric oxide-mediated/cyclic-guanosine monophosphate-independent pathway; 11. alpha2/3-selective GABAA receptor PAMs as pain medications; 12. alpha5GABAA receptors and their role in pain perception; 13. ATP sensitive potassium channels in pain and analgesia; 14. Astrocyte-neuron lactate shuttle and pain; 15.
Nociception and sweet solutions: applications to inflammatory pain; 16. Interlinking Interleukin-33 (IL-33), neuroinflammation and neuropathic pain; 17. Neurons of the parabrachial nucleus, nociceptive input and pain pathways; 18. Anterior cingulate cortex, pain perception and pathological neuronal plasticity during chronic pain; 19. Sleep deprivation headaches and Fos immunohistochemistry; 20. Antinociceptive glucagon-like peptides; 21. Pain transmission and peripheral group III metabotropic glutamate receptors (mGluRs); 22. TRPM -8 receptor and menthol in pain management II.
Physiology, imaging and physical recordings 23. Anesthetic and proconvulsant effects of ketamine on EEG; 24. Electroencephalography and anesthetic doses of ketamine; 25. Linking heart function and analgesia; 26. Computed Tomography-guided procedures for epidural injections; 27. Chronic pain: Linking deep brain stimulation and sensory functional MRI; 28. Neurocognition and placebo analgesia: linking in functional magnetic resonance imaging; 29. Linking the cortex, functional spectroscopy and pain: features and applications; 30.
Muscle origins of myofascial pain syndrome III. Psychology and Behaviour 31. Behavioral markers of pain; 32. Adverse life events, sensitization of spinal nociception, and chronic pain risk; 33. Cognitive-affective modulation of pain: The Placebo and nocebo phenomena and their impact on pain treatment; 34. Nociception-related behavioral phenotypes in adult zebrafish; 35. Pain, implantable pain devices and psychosocial aspects as a narrative; 36. Influence of psychological factors in myofascial pain IV.
Resources 37. Resources.